Clinical Trials Sponsored by Grant Medical Center

Total 27798 results

Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Preoperative Radiotherapy And ASTX660 in Rectum Cancer (PRAAR1)

Locally-advanced Rectal Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Engineering Immune Organoids to Study Pediatric Cancer (IMMUNEORGANOID)

Sarcoma | Brain Tumor | Neuroblastoma | Kidney Tumor

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors (VAPOR)

Non-Seminomatous Germ Cell Tumor

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 (MAPPYACTS2)

Leukemia | Solid Tumor

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors (PIONEER)

Solid Tumor, Adult | Solid Tumor, Childhood | Hematologic Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach (ONCOBIOTICS)

Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Pediatric Hepatic Tumors (HEPATOBIO)

Liver Tumor

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma (NIVOGLIO)

High Grade Glioma

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults (MUCILA)

Mucositis Oral

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Study of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal Irradiation (COROCAN)

Childhood Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer (ESTIMABL3)

Thyroid Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer (Liquid Biopsy)

Metastatic Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia (MONOLIFE)

Myelomonocytic Leukemia

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma (HR MB-5)

High-risk Medulloblastoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate Cancer (ODENZA)

Metastatic Castrate-resistant Prostate (CRPC) Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers (ORGANOTREAT)

Advanced, Pretreated Solid Tumors

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab (ATEZOLACC)

Locally Advanced Cervical Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer (ABIMMUNE)

Lung Cancer | Head and Neck Squamous Cell Carcinoma | Oesophageal Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors (TORS)

Head and Neck Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents (MATCH-R)

Metastatic Oncogen-driven Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients? (ESTIMABL2)

Low Risk Differentiated Thyroid Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK + (Immuno ALCL)

ALCL

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer (MEDEA)

Overweight or Obese Breast Cancer Patients

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways (MAB IN SITRO)

Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients (ONCOVID)

Cancer & COVID 19

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer (DISCOVER)

Colorectal Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients (ABC-POP)

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma (LMS02)

Uterus Leiomyosarcoma | Soft Tissue Leiomyosarcoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Feasibility of Breast Cancer Risk Evaluation in Women From the General Population (RIVIERA)

Breastcancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional Distress (TADDOR)

ENT Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer (POORTOR)

Kidney Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal Cancer (PRIMM)

Patients With Colorectal Cancer With Unresectable Synchronous Metastasis in Whom Resection of the Primitive Tumour is Indicated

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program (PETRUS)

Metastatic Castration Resistant Prostate Cancer Patients

France
Gustave Roussy, Cancer Campus, Grand Paris

Withdrawn

A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers (TAM-RT)

Anaplastic Thyroid Cancers

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Measurement of Cardiac Index Using an Implanted Central Venous Access Port in Patients Scheduled for Oncologic High-risk Surgery (ThermoD-PAC)

Oncologic High-risk Surgery

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

Lung Cancer

France, Spain, Australia, United States, Sweden, Belgium, Switzerland, Italy, Egypt, South Africa, Israel, Colombia, Morocco, Norway, Greece, Brazil, Poland, Argentina, Austria, Chile, Czech Republic, Former Yugoslavia, Japan, Lithuania, Macedonia, The Former Yugoslav Republic... and more
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment

Carcinomas

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Clinical Studies of Gemcitabine-Oxaliplatin

Osteosarcoma | Medulloblastoma | Neuroblastoma | Central Nervous System Tumors

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics

Pain | Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery

Oropharyngeal Neoplasms

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas

Uterine Sarcoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

LMBA02 Protocol for Patients With a Burkitt Lymphoma

Burkitt Lymphoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Suspended

Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia

Scheduled General Anesthesia

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract

Carcinoma, Transitional Cell

France
USDA Grand Forks Human Nutrition Research Center
Egg Nutrition Center

Terminated

Whole Egg Intake and the Mediterranean Diet

Obesity | Overweight

United States
USDA Grand Forks Human Nutrition Research Center
National Cancer Institute (NCI)

Completed

Predicting Dietary Selenium Needs to Achieve Target Blood Selenium Levels (LoDoSe)

Nutritional Requirements

United States
David Grant U.S. Air Force Medical Center
University of Rochester; Walter Reed National Military Medical Center; Uniformed... and other collaborators

Completed

Military Identity Project

Psychological Well-being | Military Identity | Self-schemas

United States
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated With High-dose Chemotherapy and Autologous Stem Cell Transplant (HGT-QoL)

Germ Cell Tumor

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors (GIG-T)

Germ Cell Tumor

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma (HOLMBRAVE)

Hepatocellular Carcinoma

France

3

Subscribe